national shortage of semaglutide and Tirzepatide No Longer in Shortage: All You Need to Know FDA: Novo Nordisk's Ozempic and

Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions

Furthermore, this non-invasive procedure promotes the breakdown of adipose tissue, leading to gradual and sustainable fat loss

Semaglutide (Ozempic, Wegovy) is a GLP-1 receptor agonist FDA-approved for type 2 diabetes and chronic weight management

June 15, 2026: Objectors Claim Bayer Misrepresented Impact of Supreme Court Decision As part of its effort to complete the pending $7.25 billion settlement, Bayer has argued that accepting the settlement is in plaintiffs' best interest since a pending ruling from the Supreme Court could cause tens of thousands of Roundup lawsuits to be dismissed